BVBiomed

BVBiomed Overview

  • Founded
  • 2012
Founded
  • Status
  • Private
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 1

BVBiomed General Information

Description

Developer of novel therapeutic compounds intended for use in treating neuro-degenerative diseases. The company's research focuses on clinical trials to test the efficacy of the pregnancy related peptide in treating acute exacerbation in multiple sclerosis, enabling users to utilize small molecule similar to relaxin for chronic treatment of the disease.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Therapeutic Devices
Other Industries
Biotechnology
Primary Office
  • Magdalen Centre, Robert Robinson Avenue
  • The Oxford Science Park
  • Oxford OX4 4GA
  • England, United Kingdom
+44 01865 000000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

BVBiomed Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 01-Jan-2015 Completed Clinical Trials - Phase 2

BVBiomed Executive Team (1)

Name Title Board Seat Contact Info
Roy Garvin Founder, Chief Science Officer & Co-Owner

BVBiomed Investors (1)

To view BVBiomed‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
OTRADI Bioscience Incubator Accelerator/Incubator Minority 000 0000 000000 0

Ready to get started?

Request a free trial